Hydrophobic acrylic IOL corrects corneal astigmatism

Article

A new hydrophobic acrylic IOL is an effective, safe and predictable method for the correction of corneal astigmatism in patients undergoing routine cataract surgery.

A new hydrophobic acrylic IOL is an effective, safe and predictable method for the correction of corneal astigmatism in patients undergoing routine cataract surgery, according to recently published data.

Dr Amy L. Sheppard et al., School of Life and Health Sciences, Aston University, Birmingham, UK, completed a cohort study in four hospital eye clinics in Europe on 67 eyes of 60 patients.

The outcome measures included uncorrected distance visual acuity (UDVA), corrected distance visual acuity, manifest refraction and keratometry. The team also documented individual patient satisfaction with uncorrected vision and the surgeon’s evaluation of ease of handling and performance of the IOL.

Four to eight weeks after cataract surgery, the mean UDVA was 0.15 logMAR ± 0.17 and UDVA was 20/40 or better in 88% of eyes. Mean refractive cylinder decreased significantly postoperatively from −1.91 ± 1.07 D to −0.67 ± 0.54 D. However, there was no change in keratometric cylinder. The good UDVA resulted in high levels of patient satisfaction.

The abstract for this study has been published in the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.